Neopharm Boston Inc. (formerly Averica Discovery Services, Inc.) is an analytical development contract research organization (CRO) with specialized expertise in small molecule analysis and purification. We work with chemistry-driven discovery and development teams to speed drug candidate selection and shorten timelines into early development.

Our Company was founded in 2007 as a source of chromatography expertise, with a leadership team having extensive experience in pharmaceutical R&D. We began using Supercritical Fluid Chromatography (SFC) technology in chiral and achiral separations, and have expanded to become a provider of a wide variety of chromatography and analytical services. These services include scalable small molecule purification, isolation and identification of impurities, and custom analytical development work.

Acquired by Neopharm Labs Inc. in late 2016, Neopharm Boston is the US laboratory and sales office for its Quebec-based parent.
Serving the Life Science industry for 25 years, Neopharm is a full service GMP analytical testing laboratory closely collaborating with pharmaceutical, medical device, natural health, veterinary, and cosmetic clients.